Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àü¸³¼± ºñ´ë¿¡¼­ ¼¼Æ÷Áõ½Ä°ú °í»ç Proliferation and Apoptosis in Prostatic Hypertrophy

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 5È£ p.454 ~ 458
ÃÖÇзæ, ÃÖ±Ô·æ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÇзæ (  ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇ°úÇבּ¸¼Ò

ÃÖ±Ô·æ (  ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

¼­·Ð
ƯÁ¤ Á¶Á÷ ¶Ç´Â Àå±âÀÇ ºñ´ë´Â À̸¦ ±¸¼ºÇÏ°í ÀÖ´Â °¢ ¼¼Æ÷¼ººÐÀÇ Áõ½Ä (hyperplasia) ¶Ç
´Â ºñ´ë(hypertrophy)°¡ ¿øÀÎÀÏ °ÍÀ¸·Î ÃßÁ¤ÇÒ ¼ö ÀÖÁö¸¸ Àü¸³¼±ºñ´ëÀÇ ÁÖµÈ º¯È­´Â ¼¼Æ÷ÀÇ
¼ö Àû Áõ°¡ÀÎ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¼¼Æ÷¼öÀÇ ±ÕÇüÀ¯Áö¿¡ ¶Ç Çϳª °í·ÁÇؾßÇÒ ¿ä¼Ò´Â, Á¤»ó¼¼
Æ÷¿¡¼­µµ ÇÊ¿¬ÀûÀ¸·Î ³ªÅ¸³ª¸ç Á¶Á÷ÀÇ Ç×»ó¼º À¯Áö¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¼¼Æ÷°í»ç
(apoptosis)ÀÏ °ÍÀÌ´Ù. µû¶ó¼­ ¿ÜÇü»ó Àü¸³¼±ºñ´ëÀÇ Á¤µµ°¡ °³Ã¼°£¿¡ Å« °ÝÂ÷¸¦ º¸Àδٴ »ç
½Ç·ÎºÎÅÍ Àü¸³¼± ºñ´ë¿¡ ´ëÇÑ °¢ ¼¼Æ÷¼ººÐÀÇ Áõ½Ä°ú °í»çÀÇ ¿ªÇÒÀ» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.
#ÃÊ·Ï#
Purpose : Volumetric change of prostate is the result of unbalanced proliferation and
apoptosis. We investigated the characteristics of proliferation and apoptosis in
hypertrophic prostate.
Materials and Methods : Proliferative and apoptotic rates were quantitated with
immunoprofiles of proliferative cell nuclear antigen(PCNA) and apoptotic body with 46
paraffin-embeded BPH specimen. When the rate of proliferation was higher than that of
apoptosis, we defined as proliferation active group.
Results: Proliferation and apoptotic rates of stromal and epithelial cells were 4.5%,
2.9% and 1.9%, 1.1%, respectively(p<0.05). There was modest correlation between
stromal volume and the proliferation rate of stromal cells(p<0.05, R=0.3209). There was
no volumetric difference in the prostate between proliferation active and inactive
group(p>0.05).
Conclusions: These results demonstrate that stromal proliferation is the main cause of
prostatic hypertrophy. The unbalance between proliferation and apoptosis of prostatic
cells seems to be unsteady in time.(Korean J Urol 1998; 39: 454¡­8)

Å°¿öµå

Benign prostatic hyperplasia; Proliferation; Apoptosis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS